About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 590376, 12 pages
http://dx.doi.org/10.1155/2013/590376
Research Article

Improvement of Liquid Fructose-Induced Adipose Tissue Insulin Resistance by Ginger Treatment in Rats Is Associated with Suppression of Adipose Macrophage-Related Proinflammatory Cytokines

1Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China
2The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, China
3College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China
4Endocrinology and Metabolism Group, Sydney Institute of Health Sciences, Sydney, NSW 2000 , Australia
5Pharmafood Institute, Kyoto 602-8136, Japan

Received 31 October 2012; Revised 25 December 2012; Accepted 12 January 2013

Academic Editor: Wen-Chin Yang

Copyright © 2013 Jianwei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Cornier, D. Dabelea, T. L. Hernandez, et al., “The metabolic syndrome,” Endocrine Reviews, vol. 29, no. 7, pp. 777–822, 2008.
  2. G. Boden, “Role of fatty acids in the pathogenesis of insulin resistance and NIDDM,” Diabetes, vol. 46, no. 1, pp. 3–10, 1997. View at Scopus
  3. A. D. Attie and P. E. Scherer, “Adipocyte metabolism and obesity,” Journal of Lipid Research, vol. 50, pp. S395–S399, 2009.
  4. A. Gastaldelli, K. Cusi, M. Pettiti et al., “Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects,” Gastroenterology, vol. 133, no. 2, pp. 496–506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Gastaldelli, S. A. Harrison, R. Belfort-Aguilar et al., “Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis,” Hepatology, vol. 50, no. 4, pp. 1087–1093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. B. A. Neuschwander-Tetri, “Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites,” Hepatology, vol. 52, no. 2, pp. 774–788, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Lomonaco, C. Ortiz-Lopez, B. Orsak, et al., “Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with NAFLD,” Hepatology, vol. 55, no. 5, pp. 1389–1397, 2012. View at Publisher · View at Google Scholar
  8. A. M. Sharma and B. Staels, “Review: peroxisome proliferator-activated receptor γ and adipose tissue–understanding obesity-related changes in regulation of lipid and glucose metabolism,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 2, pp. 386–395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. L. N. Bell, J. Wang, S. Muralidharan, et al., “Relationship between adipose tissue insulin resistance and liver histology in NASH: a PIVENS follow-up study,” Hepatology, vol. 56, no. 4, pp. 1311–1318, 2012.
  10. R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin et al., “Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?” Endocrine Reviews, vol. 30, no. 1, pp. 96–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. K. L. Stanhope, J. M. Schwarz, N. L. Keim et al., “Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans,” The Journal of Clinical Investigation, vol. 119, no. 5, pp. 1322–1334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Tappy and K. A. Le, “Metabolic effects of fructose and the worldwide increase in obesity,” Physiological Reviews, vol. 90, no. 1, pp. 23–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. N. K. Pollock, V. Bundy, W. Kanto, et al., “Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents,” Journal of Nutrition, vol. 142, no. 2, pp. 251–257, 2012. View at Publisher · View at Google Scholar
  14. A. Matsuda, Z. Wang, S. Takahashi, T. Tokuda, N. Miura, and J. Hasegawa, “Upregulation of mRNA of retinoid binding protein and fatty acid binding protein by cholesterol enriched-diet and effect of ginger on lipid metabolism,” Life Sciences, vol. 84, no. 25-26, pp. 903–907, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Nammi, M. S. Kim, N. S. Gavande, G. Q. Li, and B. D. Roufogalis, “Regulation of low-density lipoprotein receptor and 3-hydroxy-3- methylglutaryl coenzyme A reductase expression by zingiber officinale in the liver of high-fat diet-fed rats,” Basic and Clinical Pharmacology and Toxicology, vol. 106, no. 5, pp. 389–395, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Gao, T. Guan, C. Li, et al., “Treatment with ginger ameliorates fructose-induced fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element binding protein-mediated pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 570948, 12 pages, 2012. View at Publisher · View at Google Scholar
  17. X. Rong, Y. Li, K. Ebihara et al., “Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice,” Diabetologia, vol. 53, no. 8, pp. 1727–1731, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Evans, G. D. Barish, and Y. X. Wang, “PPARs and the complex journey to obesity,” Nature Medicine, vol. 10, no. 4, pp. 355–361, 2004.
  19. B. R. Barrows and E. J. Parks, “Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 4, pp. 1446–1452, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 365, no. 9468, pp. 1415–1428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Cusi, “Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis,” Clinics in Liver Disease, vol. 13, no. 4, pp. 545–563, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Vanni, E. Bugianesi, A. Kotronen, S. De Minicis, H. Yki-Järvinen, and G. Svegliati-Baroni, “From the metabolic syndrome to NAFLD or vice versa?” Digestive and Liver Disease, vol. 42, no. 5, pp. 320–330, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Fabbrini, S. Sullivan, and S. Klein, “Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications,” Hepatology, vol. 51, no. 2, pp. 679–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Bjorntorp, “Metabolic abnormalities in visceral obesity,” Annals of Medicine, vol. 24, no. 1, pp. 3–5, 1992.
  25. C. Postic and J. Girard, “Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice,” The Journal of Clinical Investigation, vol. 118, no. 3, pp. 829–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. K. E. Wellen and G. S. Hotamisligil, “Inflammation, stress, and diabetes,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111–1119, 2005.
  27. J. Ye, “Adipose tissue vascularization: its role in chronic inflammation,” Current Diabetes Reports, vol. 11, no. 3, pp. 203–210, 2011.
  28. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Galic, M. D. Fullerton, J. D. Schertzer, et al., “AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity,” The Journal of Clinical Investigation, vol. 121, no. 12, pp. 4903–4915, 2011. View at Publisher · View at Google Scholar
  30. N. Kamei, K. Tobe, R. Suzuki, et al., “Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance,” The Journal of Biological Chemistry, vol. 281, no. 36, pp. 26602–26614, 2006. View at Publisher · View at Google Scholar
  31. G. B. Di Gregorio, A. Yao-Borengasser, N. Rasouli et al., “Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone,” Diabetes, vol. 54, no. 8, pp. 2305–2313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. G. S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman, “IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance,” Science, vol. 271, no. 5249, pp. 665–668, 1996. View at Scopus
  33. M. Hoene and C. Weigert, “The role of interleukin-6 in insulin resistance, body fat distribution and energy balance,” Obesity Reviews, vol. 9, no. 1, pp. 20–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Nonogaki, G. M. Fuller, N. L. Fuentes, et al., “Interleukin-6 stimulates hepatic triglyceride secretion in rats,” Endocrinology, vol. 136, no. 5, pp. 2143–2149, 1995.
  35. M. E. Trujillo, S. Sullivan, I. Harten, S. H. Schneider, A. S. Greenberg, and S. K. Fried, “Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5577–5582, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. S. B. Biddinger and C. R. Kahn, “From mice to men: insights into the insulin resistance syndromes,” Annual Review of Physiology, vol. 68, pp. 123–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Araki, M. A. Lipes, M. E. Patti et al., “Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene,” Nature, vol. 372, no. 6502, pp. 186–190, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Tamemoto, T. Kadowaki, K. Tobe, et al., “Insulin resistance and growth retardation in mice made with targeted disruption of the IRS-1 gene,” Nature, vol. 372, no. 6502, pp. 182–186, 1994. View at Publisher · View at Google Scholar
  39. M. Benito, “Tissue specificity on insulin action and resistance: past to recent mechanisms,” Acta Physiology, vol. 201, no. 3, pp. 297–312, 2011.
  40. H. Sell and J. Eckel, “Monocyte chemotactic protein-1 and its role in insulin resistance,” Current Opinion in Lipidology, vol. 18, no. 3, pp. 258–262, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Kanda, S. Tateya, Y. Tamori et al., “MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity,” The Journal of Clinical Investigation, vol. 116, no. 6, pp. 1494–1505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. P. Weisberg, D. Hunter, R. Huber, et al., “CCR2 modulates inflammatory and metabolic effects of high-fat feeding,” Journal of Clinical Investigation, vol. 116, no. 1, pp. 115–124, 2006. View at Publisher · View at Google Scholar
  43. B. H. Ali, G. Blunden, M. O. Tanira, and A. Nemmar, “Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research,” Food and Chemical Toxicology, vol. 46, no. 2, pp. 409–420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Tripathi, K. G. Maier, D. Bruch, and D. S. Kittur, “Effect of 6-gingerol on pro-inflammatory cytokine production and costimulatory molecule expression in murine peritoneal macrophages,” Journal of Surgical Research, vol. 138, no. 2, pp. 209–213, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Dugasani, M. R. Pichika, V. D. Nadarajah, M. K. Balijepalli, S. Tandra, and J. N. Korlakunta, “Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol,” Journal of Ethnopharmacology, vol. 127, no. 2, pp. 515–520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Shim, S. Kim, D. S. Choi, Y. B. Kwon, and J. Kwon, “Anti-inflammatory effects of [6]-shogaol: potential roles of HDAC inhibition and HSP70 induction,” Food Chemical Toxicology, vol. 49, no. 11, pp. 2734–2740, 2011.
  47. H. Y. Lee, S. H. Park, M. Lee, et al., “1-Dehydro-[10]-gingerdione from gingerinhibits IKKβ activity for NF-κB activation and suppresses NF-κB-regulated expression of inflammatory genes,” British Journal of Pharmacology, vol. 167, no. 1, pp. 128–140, 2012. View at Publisher · View at Google Scholar
  48. A. Kennedy, K. Martinez, C. C. Chuang, K. Lapoint, and M. Mcintosh, “Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications,” Journal of Nutrition, vol. 139, no. 1, pp. 1–4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Talukdar, Y. O. Da, G. Bandyopadhyay, et al., “Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase,” Nature Medicine, vol. 18, no. 9, pp. 1407–1412, 2012. View at Publisher · View at Google Scholar
  50. Z. He, T. Jiang, Z. Wang, M. Levi, and J. Li, “Modulation of carbohydrate response element-binding protein gene expression in 3T3-L1 adipocytes and rat adipose tissue,” American Journal of Physiology, vol. 287, no. 3, pp. E424–E430, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Hurtado del Pozo, G. Vesperinas-García, M. Á. Rubio, et al., “ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity,” Biochimica et Biophysica Acta, vol. 1811, no. 12, pp. 1194–1200, 2011. View at Publisher · View at Google Scholar
  52. Y. Isa, Y. Miyakawa, M. Yanagisawa et al., “6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-α mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes,” Biochemical and Biophysical Research Communications, vol. 373, no. 3, pp. 429–434, 2008. View at Publisher · View at Google Scholar · View at Scopus